Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00513019
Status:
COMPLETED
Last Update Posted:
2023-02-23
First Post:
2007-08-07
Brief Title:
Double-Blind Lamictal Lamotrigine in Neurotic Excoriation
Sponsor:
University of Chicago
Organization:
University of Chicago
Study Overview
Official Title:
A Double-Blind Study of Lamictal in Neurotic Excoriation
Status:
COMPLETED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of the proposed study is to evaluate the comparative efficacy of Lamictal lamotrigine to placebo in neurotic excoriation Thirty subjects with neurotic excoriation will receive 12 weeks of double-blind treatment with Lamictal lamotrigine or matching placebo The hypothesis to be tested is that Lamictal lamotrigine will be more effective than placebo in patients with neurotic excoriation The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment
Detailed Description:
The study will consist of 12 weeks of double-blind treatment with Lamictal lamotrigine compared to placebo 11 in 30 subjects with neurotic excoriation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None